Post a Free Blog

Submit A Press Release

At CWEB, we are always looking to expand our network of strategic investors and partners. If you're interested in exploring investment opportunities or discussing potential partnerships and serious inquiries. Contact: jacque@cweb.com

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessEldorado Gold Corporation Faces Legal Scrutiny Amid Project Delays

Eldorado Gold Corporation Faces Legal Scrutiny Amid Project Delays

Add to Favorite
Added to Favorite


Eldorado Gold Corporation (NYSE:EGO) is a mining company that focuses on the exploration, development, and production of gold properties. It operates in several countries, including Greece, where it is currently developing the Skouries Project.
The company is facing scrutiny from the Rosen Law Firm due to potential securities claims. These claims suggest that Eldorado Gold may have misled investors with its business information. The investigation by the Rosen Law Firm follows a press release from Eldorado Gold on February 5, 2025.
The company revealed that labor market tightness in Greece, particularly in the construction sector, has delayed the Skouries Project. This has pushed the expected first production to the first quarter of 2026, with commercial production anticipated by mid-2026.
This announcement led to an 11.2% drop in Eldorado Gold’s stock price, closing at $14.01 on February 6, 2025. Despite these challenges, National Bank maintained its “Outperform” rating for Eldorado Gold on April 23, 2025. At that time, the stock was priced at $19.05. National Bank also raised its price target for the company from C$32 to C$36. This suggests that, despite the current issues, there is still confidence in Eldorado Gold’s long-term potential.
The Rosen Law Firm, known for its success in securities class actions, is preparing a class action to recover investor losses. The firm has a history of achieving significant settlements, including the largest securities class action settlement against a Chinese company. Shareholders who purchased Eldorado Gold securities may be eligible for compensation without any out-of-pocket costs.

Subscribe to get Latest News Updates

Latest News

You may like more
more

KBR, Inc. (NYSE:KBR) Overview: A Potential Investment Opportunity

Monthly gain of 1.20% indicates a steady upward trend...

Sanofi to Acquire Blueprint Medicines for $9.5?B, Bolstering Immunology Pipeline

French pharma leader Sanofi (NASDAQ:?SNY) announced on Monday that...

Early Use of Camizestrant Cuts Progression Risk by 56 percent in HR+/HER2– Breast Cancer

Treating women with hormone receptor–positive, HER2-negative breast cancer using...